- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01443234
OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression (OxIGen)
January 8, 2014 updated by: University of Oxford
This research study is designed to investigate the effects of an online computer program, called OxIGen (Oxford Imagery Generation), on thinking style and mood in depression.
The OxIGen program will be delivered online over four weeks and with follow-up at one, three and six months.
This will inform potential future development of this computerized task into an online intervention to modify negative thinking styles in depression.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, United Kingdom, CB2 7EF
- MRC Cognition and Brain Sciences Unit
-
-
Oxfordshire
-
Oxford, Oxfordshire, United Kingdom, OX3 7JX
- Department of Psychiatry, University of Oxford
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willing and able to give consent to the study
- Male or Female, aged between 18 and 65 years
- Current Major Depressive Episode (assessed by semi-structured clinical interview)
- Access to internet in order to complete the online program
- Able to travel to research centre for assessment appointments
- Fluent in written and spoken English
Exclusion Criteria:
- Meets criteria for current psychotic disorder
- History of mania or hypomania as assessed by semi-structured clinical interview, or has elsewhere received a diagnosis of Bipolar disorder
- Antidepressant medication begun or changed in dosage during last month
- Meets criteria for current substance abuse disorder
- Involved in other current treatment trials
- Currently receiving psychological therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: OxIGen program
Internet based intervention taking place over 4 weeks
|
Internet-based intervention with 12 sessions over 4 weeks
|
|
Placebo Comparator: OxIGen: control version
A control version of the internet-based OxIGen intervention
|
A control version of the OxIGen internet-based intervention (i.e.
identical but with putative active components removed)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in score on Beck Depression Inventory - II
Time Frame: Baseline and post-intervention (4 weeks)
|
Baseline and post-intervention (4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in score on Quick Inventory of Depressive Symptoms - Self Report
Time Frame: Baseline and post-intervention (4 weeks)
|
Baseline and post-intervention (4 weeks)
|
|
|
Change in State-Trait Anxiety Inventory (Trait scale)
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Beck Anxiety Inventory
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Scrambled Sentences Task
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Life Orientation Test - Revised
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Prospective Imagery Test
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Behavioural Activation in Depression Scale
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change in IAPT Toolkit
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Includes the GAD-7, PHQ-9 and Work and Social Adjustment Scale
|
Baseline and Post-Intervention (4 weeks)
|
|
Change on EuroQol-5D
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change in Neuroticism
Time Frame: Baseline and Post-Intervention (4 weeks)
|
Baseline and Post-Intervention (4 weeks)
|
|
|
Change on Beck Depression Inventory - II
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Quick Inventory of Depressive Symptoms - Self Report
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on State-Trait Anxiety Inventory (Trait scale)
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Beck Anxiety Inventory
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Life Orientation Test - Revised
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Prospective Imagery Test
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Behavioural Activation in Depression Scale
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on IAPT Toolkit
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Includes GAD-7, PHQ-9, Work and Social Adjustment Scale
|
Baseline and Follow-Up (one month, three months, six months)
|
|
Change on Euroqol-5D
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Change on Neuroticism
Time Frame: Baseline and Follow-Up (one month, three months, six months)
|
Baseline and Follow-Up (one month, three months, six months)
|
|
|
Image Generation Task
Time Frame: Post-Intervention (4 weeks)
|
Task adapted from Sharot et al. (2007, Nature)
|
Post-Intervention (4 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Emily A Holmes, D.Clin.Psy, PhD, University of Oxford
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
September 27, 2011
First Submitted That Met QC Criteria
September 28, 2011
First Posted (Estimate)
September 29, 2011
Study Record Updates
Last Update Posted (Estimate)
January 9, 2014
Last Update Submitted That Met QC Criteria
January 8, 2014
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11/SC/0278
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on OxIGen
-
Assaf-Harofeh Medical CenterUnknown
-
Alishia WilliamsThe University of New South WalesCompleted
-
Asociacion Latinoamericana de ToraxCompleted